102152-69-2

Upstream product

• 102152-69-2 3-(p-carbmethoxyphenyl)valeric acid 
• 1186680-40-9 4-((E)-1-benzyloxycarbonylmethylpropenyl)benzoic acid methyl ester 
• 102152-68-1 4-(1-Ethyl-but-3-enyl)-benzoic acid methyl ester 

Downstream Products

• 102152-73-8 1-chloro-4-(p-carbomethoxyphenyl)-2-hexanone 
• 102152-69-2 d-3-(p-carbmethoxyphenyl)valeric acid 
• 102152-69-2 l-3-(p-carbmethoxyphenyl)valeric acid 
• 102152-77-2 4-(4-Amino-1-ethyl-3-oxo-butyl)-benzoic acid methyl ester 
• 102152-75-0 1-azido-4-(p-carbomethoxyphenyl)-2-hexanone 

Relevant academic research and scientific papers

ALPHA-4 INTEGRIN MEDIATED CELL ADHESION INHIBITORS FOR THE TREATMENT OR PREVENTION OF INFLAMMATORY DISEASES

The present invention relates to novel compounds of formula (I), processes for their preparation, compositions comprising them and their use in the treatment or prevention of diseases capable of being modulated by the inhibition of cell adhesion.

Diastereomers of 10-alkyl-10-deazaminopterins and process for preparing the same

Diastereomers of 10-alkyl-10-deazaminopterins are provided, as well as a synthesis for their preparation as the individual d,L. and l,L.-diastereomers, the d,L-10-ethyl diastereomer being three times as potent against L1210 cells as the l,L-10-ethyl diastereomer, and the l,L-10-ethyl diastereomer being approximately one-half as toxic as the d,L-10-ethyl diastereomer.